Fierce Healthcare November 30, 2023
Virtual care giant Teladoc recently expanded its telehealth services to include prescribing obesity medications as it sees opportunities in the booming weight management market.
But, the employer market continues to be in a state of flux as many organizations are taking a cautious approach to covering newer obesity drugs such as GLP-1s, short for glucagon-like peptide 1 agonists.
Up until recently, Teladoc was offering provider-based care services to diabetes and hypertension patients. During the third quarter, the company expanded this service for employers to include weight management and prediabetes programs.
“Certainly the introduction of provider-based care to our weight management program and especially diabetes prevention, that is absolutely in response to the proliferation of GLP-1s,” Teladoc CEO Jason Gorevic...